Catalent Opens Cell Therapy Manufacturing Facilities in Belgium

Catalent has announced the completion and opening of one of the world’s largest commercial-scale cell therapy manufacturing facility at its European center of excellence for cell therapies, in Gosselies, Belgium.

Article Summary

The new facility is established with 60,000 square feet (5,600 square meters) of dedicated cell therapy manufacturing space housing multi-product, segregated suites designed to support autologous and allogeneic cell therapy manufacturing through to late-stage clinical and commercial-scale supply. The facility has been designed to be EMEA and FDA compliant, with Grade B and C suites to support high-throughput processes and accommodate bioreactor-scale cell therapy manufacturing as well as on-site quality control (QC) laboratories and warehousing.

The newly completed facility is the latest addition to Catalent’s Gosselies campus, which already includes a 67,000-square-foot (6,200-square-meter) clinical manufacturing facility offering customers advanced clinical and commercial supply solutions. The overall Gosselies campus provides a one-stop shop, with process and analytical development labs, more than 20 CGMP grade B and C cleanrooms, dedicated QC labs, qualified person (QP) services, and warehousing.


(Source: Catalent, 8th December 2022)


Leave A Comment

Leave a Reply

Your email address will not be published.